Barrington Research Reaffirms “Outperform” Rating for Adtalem Global Education (NYSE:CVSA)

Adtalem Global Education (NYSE:CVSA)‘s stock had its “outperform” rating reissued by equities research analysts at Barrington Research in a note issued to investors on Friday,Benzinga reports. They currently have a $170.00 price objective on the stock. Barrington Research’s price objective suggests a potential upside of 43.33% from the stock’s previous close.

Several other equities analysts have also commented on the stock. Truist Financial started coverage on shares of Adtalem Global Education in a research report on Tuesday, March 24th. They set a “buy” rating and a $130.00 price objective for the company. Zacks Research lowered shares of Adtalem Global Education from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, March 25th. Finally, Weiss Ratings started coverage on shares of Adtalem Global Education in a research report on Wednesday, February 25th. They set a “hold (c+)” rating for the company. Two research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $150.00.

Adtalem Global Education Price Performance

CVSA stock traded up $2.61 during trading on Friday, hitting $118.61. 89,523 shares of the company’s stock traded hands, compared to its average volume of 405,127. Adtalem Global Education has a 52 week low of $86.97 and a 52 week high of $156.26. The company has a quick ratio of 0.68, a current ratio of 0.68 and a debt-to-equity ratio of 0.37. The firm has a market capitalization of $4.09 billion, a P/E ratio of 17.40, a price-to-earnings-growth ratio of 0.95 and a beta of 0.63.

Adtalem Global Education (NYSE:CVSA) last released its quarterly earnings data on Wednesday, January 28th. The company reported $2.43 EPS for the quarter. Adtalem Global Education had a net margin of 13.41% and a return on equity of 20.24%. The business had revenue of $503.39 million during the quarter.

Insider Buying and Selling

In related news, Director Michael W. Malafronte purchased 15,305 shares of Adtalem Global Education stock in a transaction that occurred on Tuesday, March 10th. The shares were bought at an average price of $100.86 per share, with a total value of $1,543,662.30. Following the purchase, the director directly owned 16,505 shares of the company’s stock, valued at approximately $1,664,694.30. This represents a 1,275.42% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Over the last quarter, insiders have bought 37,236 shares of company stock valued at $3,752,866. Company insiders own 2.50% of the company’s stock.

Adtalem Global Education Company Profile

Adtalem Global Education (NYSE: CVSA) is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.

Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.